Peptides are short chains of amino acids that act as signaling molecules in the body, and 'peptide therapy' has become a popular wellness offering. At Aloha Stem Cell we believe in honest, evidence-based care, which means being clear about what the science supports and what it does not. This article explains what peptides are, where the evidence stands, and the questions worth asking before any wellness peptide.
1
human study among 36 reviewed on popular wellness peptides
0
FDA-approved uses for most wellness peptides
5
clinical providers on the team
Peptides are small proteins that can influence how cells communicate. Some, like the GLP-1 receptor agonists used for type 2 diabetes and weight loss, are genuinely FDA-approved drugs with strong evidence. The wider 'wellness peptide' category, including compounds many people hear about online, is a different story entirely: most have little or no human research behind them.
A 2025 review of studies on popular wellness peptides found that of 36 studies reviewed, 35 were conducted entirely in animals and only one was a small human case series. In plain terms, most wellness peptides are sold with confidence far ahead of the evidence. Claims about muscle growth, longevity, recovery, or tissue repair rarely rest on the kind of randomized human trials that would establish safety and effectiveness.
Most wellness peptides are not FDA-approved for any human use, and the agency has moved to restrict the compounding of several of them, including BPC-157, TB-500, and GHK-Cu, citing the lack of randomized, placebo-controlled human trials. FDA testing has also found that a large share of online or compounded peptides contain incorrect dosages or undeclared ingredients, which raises real safety concerns beyond just whether they work.
“Most wellness peptides are not FDA-approved for any human use, and the FDA has flagged several, including BPC-157, as unsafe for compounding because they lack randomized, placebo-controlled human trials.”
Because many peptides are compounded on site or bought online, quality control is a genuine concern. Risks can include contaminated or mislabeled product, injection-site reactions, allergic responses, hormonal imbalances, and effects on tightly regulated hormone pathways. A responsible clinic does not hand over a vial of a compound it cannot source, document, and justify.
A note from the clinic
Honesty is the foundation of good care. At Aloha Stem Cell we are transparent about what the evidence supports and what it does not, and we never sell a product we cannot stand behind. If you are curious about peptides, weight loss, or recovery, call (808) 593-2525 and talk it through with our team.
Our team is happy to listen to your story, answer your questions, and help you decide whether a consultation makes sense. There is no pressure and no obligation.
Keep reading
The FDA now lists Regenecyte, a cord blood stem cell product, among approved cellular therapies. It is a real milestone for blood stem cell transplant patients, and it is not a treatment for joint pain. Here is what the approval is, what it is not, and why it matters when you read stem cell news.
In September 2026 the FDA granted Fast Track status to an experimental cell therapy for ALS, and in August researchers presented new Phase 1/2 data on a stem cell therapy for Parkinson's. Both are real advances and both remain investigational. Here is the honest read.
A stem cell-derived islet therapy restored insulin production in early trials, with 10 of 12 patients insulin-independent at one year. Here is what the 2025-2026 results show, what the FDA has and has not done, and what it means for people with diabetes.
Book a consultation
Pick a time that works for you and our team will confirm your consultation. Questions first? Call us anytime at (808) 593-2525.